FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:365-367 August 1, 2002 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Bigger, J. T. Related Article by Moss, A. J. PubMed Citation

To the Editor: Moss et al. (March 21 issue)¹ describe a randomized, controlled clinical trial designed to test the expansion of the indications for implanting a cardiac defibrillator. The maker of the defibrillator paid for the trial, which was conducted by experts in the procedure that uses the defibrillator. The results demonstrate an unquestionable 31 percent decrease in mortality among those who underwent the prophylactic procedure. The accompanying editorial by Bigger² cites the need for additional data and longer follow-up and implies that expanding the indications for the procedure may be premature. Nevertheless, nationally prominent cardiologists perceive the results of . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.